Department of Pharmacy, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand.
Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
Int J Clin Pharm. 2019 Aug;41(4):880-887. doi: 10.1007/s11096-019-00832-4. Epub 2019 May 3.
Background Little information is available regarding pharmacist's intervention to solve drug-related problems (DRPs) in a stroke unit. Objective To investigate the nature and frequency of DRPs along with the role of pharmacists in a stroke unit. Setting The study was conducted at the stroke unit of Siriraj hospital, a university affiliated tertiary care hospital in Thailand. Method A retrospective descriptive study of DRPs and pharmacists' interventions for stroke patients was performed during July 2015 to December 2016. Data were collected from patient's medical records and pharmacist's intervention record forms. DRPs were categorized using the Hepler-Strand classification. The stroke pharmacist team, consisting of a board-certified pharmacotherapy specialist, neurology pharmacy residents and stroke unit pharmacists, participated in the multidisciplinary ward round in the stroke unit 5 days a week. All patients were visited by a member of the stroke pharmacist team within the first two days of their admission to conduct a thorough review of drug therapy for every patient and provided appropriate recommendation to the multidisciplinary team either verbally during the ward round or with written information in the patients' medical charts, as appropriate. Main Outcome Measure (a) incidence and characteristics of DRPs (b) types and the acceptance of pharmacists' interventions. Results A total of 859 patients were admitted, of those, 768 patients had ≥ 1 DRPs and a total of 796 DRPs were identified. Clinical pharmacists provided 659 interventions to the multidisciplinary team. The most common DRPs identified were "untreated indications" (22.6%) and "non-compliance" (21.0%). Of all DRPs, 74.6% were stroke related issues. The most implicated drugs were antihypertensive drugs, followed by antithrombotic therapies. The multidisciplinary team accepted 84.7% of pharmacists' interventions. Conclusion DRP in a stroke unit is common. Clinical pharmacists in a stroke unit can effectively reduce and prevent DRPs with the focus on performing medication reconciliation, providing recommendation on dosage adjustment and proper drug selection for stroke patients.
关于药剂师在卒中单元解决药物相关问题(DRP)的干预措施,相关信息有限。目的:调查卒中单元中 DRP 的性质和频率以及药剂师的作用。地点:该研究在泰国 Siriraj 医院的卒中单元进行,该医院是一家隶属于大学的三级保健医院。方法:2015 年 7 月至 2016 年 12 月,对卒中患者的 DRP 和药剂师干预进行回顾性描述性研究。数据从患者的病历和药剂师干预记录中收集。DRP 采用 Hepler-Strand 分类法进行分类。卒中药剂师团队由一名经过董事会认证的药物治疗专家、神经病学药房住院医师和卒中单元药剂师组成,每周 5 天在卒中单元参加多学科病房查房。所有患者在入院的前两天内都会由卒中药剂师团队的成员进行药物治疗的全面审查,并根据需要通过病房查房口头或在患者病历中书面提供适当的建议给多学科团队。主要结果:(a)DRP 的发生率和特征;(b)药剂师干预的类型和接受程度。结果:共有 859 名患者入院,其中 768 名患者有≥1 个 DRP,共发现 796 个 DRP。临床药师向多学科团队提供了 659 项干预措施。最常见的 DRP 是“未治疗的适应症”(22.6%)和“不依从”(21.0%)。所有 DRP 中,74.6%与卒中相关。最涉及的药物是降压药,其次是抗血栓治疗药物。多学科团队接受了 84.7%的药剂师干预。结论:卒中单元中的 DRP 很常见。卒中单元的临床药师可以通过专注于进行药物重整、为卒中患者提供剂量调整和适当药物选择的建议,有效地减少和预防 DRP。